Unternehmen Intellicell Biosciences Inc OTC Bulletin Board
Aktien
US45825A1051
Biotechnologie
Schlusskurs
Andere Börsenplätze
|
||
- USD | - |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Steven A. Victor
CEO | Chief Executive Officer | 71 | 03.06.11 |
Anna Rhodes
PRN | Corporate Officer/Principal | - | 03.06.11 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Steven A. Victor
CEO | Chief Executive Officer | 71 | 03.06.11 |
Harold Bafitis
BRD | Director/Board Member | - | - |
Greg Cavaliere
BRD | Director/Board Member | - | - |
Gil Chimes
BRD | Director/Board Member | - | - |
Director/Board Member | - | - | |
Joshua Hackel
BRD | Director/Board Member | - | - |
Frederick Nicola
BRD | Director/Board Member | - | - |
Wilson Tawe
BRD | Director/Board Member | - | - |
Nicholas Toscano
BRD | Director/Board Member | - | - |
Erich Richter
BRD | Director/Board Member | - | - |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 0 | 56 500 | 0 | 0 | 100,00 % |
Aktie B | 0 | 7 250 | 0 | 0 | |
Aktie C | 1 | 7 894 037 082 | 7 894 037 082 ( 100,00 %) | 0 | |
Aktie D | 0 | 15 057 | 0 | 0 |
Unternehmenskontakt
Intellicell Biosciences, Inc.
460 Park Avenue 17th floor
10022, New York
+
http://www.intellicellbiosciences.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+51,85 % | 57,87 Mrd. | |
+41,42 % | 40,25 Mrd. | |
-5,25 % | 39,94 Mrd. | |
-5,16 % | 28,54 Mrd. | |
+12,79 % | 26,4 Mrd. | |
-20,18 % | 19,33 Mrd. | |
+30,88 % | 12,4 Mrd. | |
+0,61 % | 12,23 Mrd. | |
+25,06 % | 12,2 Mrd. |